High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma
A Randomized Trial to Evaluate Early High Dose Therapy and Autologous Bone Marrow Transplantation as Part of Planned Initial Therapy for Poor Risk Intermediate/High Grade NHL
Sponsor: Lymphoma Trials Office
Listed as NCT00003578, this PHASE3 trial focuses on Lymphoma and remains ongoing. Sponsored by Lymphoma Trials Office, it has been updated 6 times since 1993, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Jan 1993
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lymphoma Trials Office
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aarhus, Denmark, Aylesbury-Buckinghamshire, United Kingdom, Bangor, United Kingdom, Bath, United Kingdom, Belfast, United Kingdom, Birmingham, United Kingdom, Bournemouth, United Kingdom, Bristol, United Kingdom, Burton-on-Trent, United Kingdom, Canterbury, United Kingdom and 47 more location s